Keith Rotenberg

Keith Rotenberg is a seasoned pharmaceutical executive with extensive experience in research and development, board leadership, and company formation. As the President of Rotenberg Consultants, LLC since June 2017, and a Board Member at Holmdel Pharmaceuticals, LLC since December 2012, Keith has played pivotal roles in guiding pharmaceutical ventures. Additionally, Keith founded Mist Pharmaceuticals, LLC in June 2011, serving as both Founder and Board Member. From 2012 to 2018, Keith held the position of Corporate Vice President and Chief Scientific Officer at Akrimax Pharmaceuticals, LLC, where Keith had previously served as VP and Chief Scientific Officer from 2008 to 2010. Previous positions include Chief Scientific Officer at Triax Pharmaceuticals and Senior Vice President of R & D at Reliant Pharmaceuticals. Academic credentials include a Ph.D. in Pharmacokinetics/Biopharmaceutics from the University of Maryland Baltimore and a Bachelor of Arts in Bacteriology from the University of California, Berkeley.